Connection
Susan Lana to Dogs
This is a "connection" page, showing publications Susan Lana has written about Dogs.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.794 |
|
|
|
-
Wolf-Ringwall A, Lopez L, Elmslie R, Fowler B, Lori J, Sfiligoi G, Skope A, Arnold E, Hughes KL, Thamm DH, Ehrhart EJ, Avery AC, Lana SE. Prospective evaluation of flow cytometric characteristics, histopathologic diagnosis and clinical outcome in dogs with naïve B-cell lymphoma treated with a 19-week CHOP protocol. Vet Comp Oncol. 2020 Sep; 18(3):342-352.
Score: 0.134
-
Selmic LE, Lafferty MH, Kamstock DA, Garner A, Ehrhart NP, Worley DR, Withrow SJ, Lana SE. Outcome and prognostic factors for osteosarcoma of the maxilla, mandible, or calvarium in dogs: 183 cases (1986-2012). J Am Vet Med Assoc. 2014 Oct 15; 245(8):930-8.
Score: 0.094
-
Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014 Mar-Apr; 28(2):554-63.
Score: 0.090
-
Warry E, Bohn A, Emanuelli M, Thamm D, Lana S. Disease distribution in canine patients with acanthocytosis: 123 cases. Vet Clin Pathol. 2013 Dec; 42(4):465-70.
Score: 0.089
-
Forster GM, Hill D, Gregory G, Weishaar KM, Lana S, Bauer JE, Ryan EP. Effects of cooked navy bean powder on apparent total tract nutrient digestibility and safety in healthy adult dogs. J Anim Sci. 2012 Aug; 90(8):2631-8.
Score: 0.078
-
Marcus EC, Marolf A, Thamm DH, Lana SE. What is your diagnosis? Extraskeletal osteosarcoma. J Am Vet Med Assoc. 2012 Feb 01; 240(3):265-6.
Score: 0.078
-
Warry E, Hansen RJ, Gustafson DL, Lana SE. Pharmacokinetics of cyclophosphamide after oral and intravenous administration to dogs with lymphoma. J Vet Intern Med. 2011 Jul-Aug; 25(4):903-8.
Score: 0.074
-
Lana S, U'ren L, Plaza S, Elmslie R, Gustafson D, Morley P, Dow S. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. J Vet Intern Med. 2007 Jul-Aug; 21(4):764-9.
Score: 0.057
-
Kraft S, Randall E, Wilhelm M, Lana S. Development of a whole body magnetic resonance imaging protocol in normal dogs and canine cancer patients. Vet Radiol Ultrasound. 2007 May-Jun; 48(3):212-20.
Score: 0.056
-
Gaines PJ, Powell TD, Walmsley SJ, Estredge KL, Wisnewski N, Stinchcomb DT, Withrow SJ, Lana SE. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry. Am J Vet Res. 2007 Apr; 68(4):405-10.
Score: 0.056
-
Lana SE, Kogan LR, Crump KA, Graham JT, Robinson NG. The use of complementary and alternative therapies in dogs and cats with cancer. J Am Anim Hosp Assoc. 2006 Sep-Oct; 42(5):361-5.
Score: 0.054
-
Lana S, Plaza S, Hampe K, Burnett R, Avery AC. Diagnosis of mediastinal masses in dogs by flow cytometry. J Vet Intern Med. 2006 Sep-Oct; 20(5):1161-5.
Score: 0.054
-
Lana SE, Jackson TL, Burnett RC, Morley PS, Avery AC. Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma. J Vet Intern Med. 2006 Mar-Apr; 20(2):329-34.
Score: 0.052
-
Mullins MN, Dernell WS, Withrow SJ, Ehrhart EJ, Thamm DH, Lana SE. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004). J Am Vet Med Assoc. 2006 Jan 01; 228(1):91-5.
Score: 0.051
-
Das S, Schlemmer SN, Idate R, Lana SE, Regan DP, Thamm DH, Duval DL. Comparative genomic and clinicopathological analysis uncovers contrasting molecular profiles of canine and human thyroid carcinomas. Commun Biol. 2025 Dec 06; 9(1):4.
Score: 0.051
-
Hillers KR, Dernell WS, Lafferty MH, Withrow SJ, Lana SE. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc. 2005 Apr 15; 226(8):1364-7.
Score: 0.049
-
Lana SE, Dernell WS, Lafferty MH, Withrow SJ, LaRue SM. Use of radiation and a slow-release cisplatin formulation for treatment of canine nasal tumors. Vet Radiol Ultrasound. 2004 Nov-Dec; 45(6):577-81.
Score: 0.047
-
Das S, Idate R, Lana SE, Regan DP, Duval DL. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions. Sci Rep. 2023 06 27; 13(1):10422.
Score: 0.043
-
Slinkard PT, Lana SE, Frank CB, Griffin LR. Multi-modality imaging and therapeutics used in a case of canine spinal nephroblastoma. Can Vet J. 2022 08; 63(8):811-818.
Score: 0.040
-
Nolan MW, Uzan OC, Green NA, Lana SE, Lascelles BDX. Intensity of perioperative analgesia but not pre-treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma. Vet Comp Oncol. 2022 Sep; 20(3):568-576.
Score: 0.039
-
Frankhouse KA, Rout ED, Hughes KL, Labadie JD, Yoshimoto JA, Lana SE, Avery PR, Avery AC. An aggressive CD4- CD8- T-cell neoplasm in young English bulldogs. Vet Comp Oncol. 2022 Jun; 20(2):416-426.
Score: 0.039
-
Das S, Idate R, Regan DP, Fowles JS, Lana SE, Thamm DH, Gustafson DL, Duval DL. Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma. Commun Biol. 2021 10 11; 4(1):1178.
Score: 0.038
-
Cronise KE, Das S, Hernandez BG, Regan DP, Dailey DD, McGeachan RI, Lana SE, Page RL, Gustafson DL, Duval DL. Characterizing the molecular and immune landscape of canine bladder cancer. Vet Comp Oncol. 2022 Mar; 20(1):69-81.
Score: 0.037
-
LeBlanc AK, Mazcko CN, Cherukuri A, Berger EP, Kisseberth WC, Brown ME, Lana SE, Weishaar K, Flesner BK, Bryan JN, Vail DM, Burton JH, Willcox JL, Mutsaers AJ, Woods JP, Northrup NC, Saba C, Curran KM, Leeper H, Wilson-Robles H, Wustefeld-Janssens BG, Lindley S, Smith AN, Dervisis N, Klahn S, Higginbotham ML, Wouda RM, Krick E, Mahoney JA, London CA, Barber LG, Balkman CE, McCleary-Wheeler AL, Suter SE, Martin O, Borgatti A, Burgess K, Childress MO, Fidel JL, Allstadt SD, Gustafson DL, Selmic LE, Khanna C, Fan TM. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs. Clin Cancer Res. 2021 06 01; 27(11):3005-3016.
Score: 0.037
-
Lana SE, Ogilvie GK, Hansen RA, Powers BE, Dernell WS, Withrow SJ. Identification of matrix metalloproteinases in canine neoplastic tissue. Am J Vet Res. 2000 Feb; 61(2):111-4.
Score: 0.034
-
Lana SE, Dernell WS, LaRue SM, Lafferty MJ, Douple EB, Brekke JH, Withrow SJ. Slow release cisplatin combined with radiation for the treatment of canine nasal tumors. Vet Radiol Ultrasound. 1997 Nov-Dec; 38(6):474-8.
Score: 0.029
-
Curran KM, Schaffer PA, Frank CB, Lana SE, Hamil LE, Burton JH, Labadie J, Ehrhart EJ, Avery PR. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy. Vet Comp Oncol. 2017 Dec; 15(4):1269-1279.
Score: 0.027
-
Rodrigues LC, Holmes KE, Thompson V, Piskun CM, Lana SE, Newton MA, Stein TJ. Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns. Vet Comp Oncol. 2016 Jun; 14(2):e58-69.
Score: 0.024
-
Modiano JF, Bellgrau D, Cutter GR, Lana SE, Ehrhart NP, Ehrhart E, Wilke VL, Charles JB, Munson S, Scott MC, Pozniak J, Carlson CS, Schaack J, Duke RC. Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer. Mol Ther. 2012 Dec; 20(12):2234-43.
Score: 0.020
-
Rao S, Lana S, Eickhoff J, Marcus E, Avery PR, Morley PS, Avery AC. Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma. J Vet Intern Med. 2011 Sep-Oct; 25(5):1097-105.
Score: 0.019
-
Hahn KA, Legendre AM, Shaw NG, Phillips B, Ogilvie GK, Prescott DM, Atwater SW, Carreras JK, Lana SE, Ladue T, Rusk A, Kinet JP, Dubreuil P, Moussy A, Hermine O. Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Am J Vet Res. 2010 Nov; 71(11):1354-61.
Score: 0.018
-
Devitt JJ, Maranon DG, Ehrhart EJ, Bachand AM, Lana SE, LaRue SM. Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma. Cytogenet Genome Res. 2009; 124(1):12-8.
Score: 0.016
-
Miller AG, Morley PS, Rao S, Avery AC, Lana SE, Olver CS. Anemia is associated with decreased survival time in dogs with lymphoma. J Vet Intern Med. 2009 Jan-Feb; 23(1):116-22.
Score: 0.016
-
Rebhun RB, Lana SE, Ehrhart EJ, Charles JB, Thamm DH. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma. J Vet Intern Med. 2008 Jul-Aug; 22(4):989-95.
Score: 0.015
-
Petty JC, Lana SE, Thamm DH, Charles JB, Bachand AM, Bush JM, Ehrhart EJ. Glucose transporter 1 expression in canine osteosarcoma. Vet Comp Oncol. 2008 Jun; 6(2):133-40.
Score: 0.015
-
Williams MJ, Avery AC, Lana SE, Hillers KR, Bachand AM, Avery PR. Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. J Vet Intern Med. 2008 May-Jun; 22(3):596-601.
Score: 0.015
-
Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VE, Getzy DM, Smith TL, Gardner LA, Ritt MG, Bell JS, Freeman KP, Greenfield BE, Lana SE, Kisseberth WC, Helfand SC, Cutter GR, Breen M, Modiano JF. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma. Vet Pathol. 2007 Jul; 44(4):467-78.
Score: 0.014
-
Hillers KR, Lana SE, Fuller CR, LaRue SM. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc. 2007 Jul-Aug; 43(4):187-92.
Score: 0.014
-
Walter CU, Biller BJ, Lana SE, Bachand AM, Dow SW. Effects of chemotherapy on immune responses in dogs with cancer. J Vet Intern Med. 2006 Mar-Apr; 20(2):342-7.
Score: 0.013
-
Selting KA, Ogilvie GK, Gustafson DL, Long ME, Lana SE, Walton JA, Hansen RA, Turner AS, Laible I, Fettman MJ. Evaluation of the effects of dietary n-3 fatty acid supplementation on the pharmacokinetics of doxorubicin in dogs with lymphoma. Am J Vet Res. 2006 Jan; 67(1):145-51.
Score: 0.013
-
Williams LE, Rassnick KM, Power HT, Lana SE, Morrison-Collister KE, Hansen K, Johnson JL. CCNU in the treatment of canine epitheliotropic lymphoma. J Vet Intern Med. 2006 Jan-Feb; 20(1):136-43.
Score: 0.013
-
Mullins MN, Lana SE, Dernell WS, Ogilvie GK, Withrow SJ, Ehrhart EJ. Cyclooxygenase-2 expression in canine appendicular osteosarcomas. J Vet Intern Med. 2004 Nov-Dec; 18(6):859-65.
Score: 0.012
-
Williams LE, Gliatto JM, Dodge RK, Johnson JL, Gamblin RM, Thamm DH, Lana SE, Szymkowski M, Moore AS. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995). J Am Vet Med Assoc. 2003 Sep 15; 223(6):825-31.
Score: 0.011
-
Kazmierski KJ, Ogilvie GK, Fettman MJ, Lana SE, Walton JA, Hansen RA, Richardson KL, Hamar DW, Bedwell CL, Andrews G, Chavey S. Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma. J Vet Intern Med. 2001 Nov-Dec; 15(6):585-8.
Score: 0.010
-
Leibman NF, Lana SE, Hansen RA, Powers BE, Fettman MJ, Withrow SJ, Ogilvie GK. Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. J Vet Intern Med. 2000 Nov-Dec; 14(6):583-6.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|